Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with egfr and ron kinase to sustain carcinoma cell cycle progression

HIGHLIGHTS

• who: DeannaLee M. Beauvais from the DeannaLee MBeauvais, Scott E. Nelson, Kristin M. Adams, Noah A. Stueven, Oisun Jung, and Alan C. Rapraeger* From the Department of Human Oncology, University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA Edited by Eric Fearon have published the article: Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustainu00a0carcinoma cell cycle progression, in the Journal: (JOURNAL) of September/16,/2021
• future: Future studies will be required to identify the target of ABL1 that restricts p38MAPK J. Biol.
 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.